Trial · NCT01181479
Results by group26
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 26
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Pregnancy | AG200-15 for Cycle 7-13 | 5.41 | 95% Confidence Interval 2.35 to 8.46 | Pearl Index | |
| Pregnancy | Lessina | 6.67 | 95% Confidence Interval 0.84 to 12.5 | Pearl Index | |
| Pregnancy | AG200-15 for Cycle 1-13 | 6.43 | 95% Confidence Interval 4.13 to 8.72 | Pearl Index | |
| Cycle Control | AG200-15 for Cycle 1-6 | 23.9 | percentage of cycles with BTB/BTS | ||
| Cycle Control | Lessina | 21.2 | percentage of cycles with BTB/BTS | ||
| Pharmacokinetics of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) | Lessina Cycles 1-6 | EE for cycle 2 | 35.4 | 95% Confidence Interval 31.9 to 38.8 | pg/ml |
| Pharmacokinetics of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) | AG200-15 for Cycle 1-13 | EE for cycle 2 | 30.5 | 95% Confidence Interval 29.0 to 32.1 | pg/ml |
| Pharmacokinetics of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) | AG200-15 for Cycles 7-13 | EE for cycle 2 | NA | 95% Confidence Interval NA to NA | pg/ml |
| Pharmacokinetics of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) | Lessina Cycles 1-6 | EE cycle 6 | 40.1 | 95% Confidence Interval 33.3 to 46.9 | pg/ml |
| Pharmacokinetics of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) | AG200-15 for Cycle 1-13 | EE cycle 6 | 36.7 | 95% Confidence Interval 34.3 to 39.0 | pg/ml |
| Pharmacokinetics of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) | AG200-15 for Cycles 7-13 | EE cycle 6 | NA | 95% Confidence Interval NA to NA | pg/ml |
| Pharmacokinetics of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) | Lessina Cycles 1-6 | EE cycle 13 | NA | 95% Confidence Interval NA to NA | pg/ml |
| Pharmacokinetics of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) | AG200-15 for Cycle 1-13 | EE cycle 13 | 31 | 95% Confidence Interval 28.5 to 33.5 | pg/ml |
| Pharmacokinetics of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) | AG200-15 for Cycles 7-13 | EE cycle 13 | 33.4 | 95% Confidence Interval 29.1 to 37.8 | pg/ml |
| Pharmacokinetics of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) | Lessina Cycles 1-6 | LNG cycle 2 | 2386 | 95% Confidence Interval 2180 to 2592 | pg/ml |
| Pharmacokinetics of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) | AG200-15 for Cycle 1-13 | LNG cycle 2 | 1201 | 95% Confidence Interval 1136 to 1266 | pg/ml |
| Pharmacokinetics of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) | AG200-15 for Cycles 7-13 | LNG cycle 2 | NA | 95% Confidence Interval NA to NA | pg/ml |
| Pharmacokinetics of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) | Lessina Cycles 1-6 | LNG cycle 6 | 2611 | 95% Confidence Interval 2355 to 2867 | pg/ml |
| Pharmacokinetics of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) | AG200-15 for Cycle 1-13 | LNG cycle 6 | 1753 | 95% Confidence Interval 1636 to 1871 | pg/ml |
| Pharmacokinetics of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) | AG200-15 for Cycles 7-13 | LNG cycle 6 | NA | 95% Confidence Interval NA to NA | pg/ml |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01181479/results